Obsessive-compulsive disorder (OCD) Investigational Medication

Recruiting

18 years - 75 years

All

Phase N/A

10 participants needed

1 Location

Brief description of study

The Center for the Treatment and Study of Anxiety is offering an investigational medication for people who have obsessive-compulsive disorder (OCD) and are currently taking an SRI medication for their OCD but still have unwanted symptoms.

Detailed description of study

The Center for the Treatment and Study of Anxiety is offering an investigational medication for people who have obsessive-compulsive disorder (OCD) and are currently taking one of the below medications for their OCD but still have unwanted symptoms.

Are you taking one of the following medications for obsessive-compulsive disorder?

Clomipramine (Anafranil)

Fluoxetine (Prozac)

Fluvoxamine (Luvox)

Sertraline (Zoloft)

Paroxetine (Paxil)

Citalopram (Celexa)

Escitalopram (Lexapro)

Eligible participants remain on a stable dose of their OCD medication in the first part of the study, and will receive an investigational medication or a placebo as additional treatment for 10 weeks. Individuals who do not improve will be referred elsewhere to receive appropriate clinical treatment.

Men and women ages 18-75 with OCD who are currently taking an SRI medication (Prozac, Zoloft, Paxil, Luvox, Celexa, Lexapro or Anafranil) may be eligible to participate in this study. There is no cost for this study. Participants may be compensated to $525 for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: OCD,Obessive Compulsive Disorder
Age: 18 years - 75 years
Gender: All

Updated on 19 Feb 2024. Study ID: 828488

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).